Live feed
·
INSIDERFilingvia Quantisnow
BioVie Inc. logo

BioVie (BIVI) director Berman received 43,578 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Richard J Berman (director at BioVie Inc., BIVI) reported that they received 43,578 shares on Nov 23, 2022. After these transactions the filing shows 45,178 shares held directly.

Reporting person
Berman Richard J
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Nov 23, 2022Grant or award (A)COMMON STOCK+43,578--45,178 direct

Holdings before and after

  • COMMON STOCK: 1,600 to 45,178 direct

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Berman report in this BIVI Form 4?

Richard J Berman (director at BioVie Inc., BIVI) reported that they received 43,578 shares on Nov 23, 2022. After these transactions the filing shows 45,178 shares held directly.

How many BIVI shares does Berman hold after this filing?

The filing shows 45,178 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for BIVI

Earlier insider filings at BIVI

Quantisnow market dataNASDAQ
BioVie Inc. logo
BIVI
BioVie Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for BIVI

Follow BIVI and get a push notification the moment its next story breaks.

Full BIVI profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIVI (BioVie Inc.) and more on Quantisnow.